MetaADEDB 2.0 @ LMMD
samarium Sm-153 lexidronam
(NSIATQGMQRDOCS-NKNBZPHVSA-J)
Structure
SMILES
[O-]P(=O)(CN(CP(=O)(O)[O-])CCN(CP(=O)(O)[O-])CP(=O)(O)[O-])O.[Na+].[Na+].[Na+].[Na+].[Na+].[153Sm]
Molecular Formula:
C6H16N2Na5O12P4Sm+
Molecular Weight:
699.963
Log P:
-0.1160
Hydrogen Bond Acceptor:
14
Hydrogen Bond Donor:
4
TPSA:
287.16
CAS Number(s):
176669-18-4
Synonym(s)
1.
samarium Sm-153 lexidronam
2.
153Sm-EDTMP
3.
Quadramet
4.
Sm-EDTMP
5.
samarate(5-)-153Sm, (((1,2-ethanediylbis((nitrilo-kappa-N)bis(methylene)))tetrakis(phosphonato-kappa-O))(8-))-, pentahydrogen, (oc-6-21)
6.
samarium (153Sm) lexidronam
7.
samarium ethylenediaminetetramethylenephosphonate
8.
samarium-153 lexidronam
9.
samarium-153-EDTMP
External Link(s)
MeSHC061972
PubChem Compound56841803
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1ThrombocytopeniaFAERS: 9US FAERS
2PainFAERS: 7OFFSIDES
US FAERS
3ArthralgiaFAERS: 4US FAERS
4Disease ProgressionFAERS: 4OFFSIDES
US FAERS
5Back PainFAERS: 3US FAERS
6AstheniaFAERS: 2US FAERS
7OsteolysisFAERS: 2OFFSIDES
US FAERS
8Pathological fractureFAERS: 2US FAERS
9ProctitisFAERS: 2OFFSIDES
US FAERS
10Atrial FibrillationFAERS: 1US FAERS
11Blood count abnormalFAERS: 1US FAERS
12Blood creatinine increasedFAERS: 1OFFSIDES
US FAERS
13Blood urea increasedFAERS: 1OFFSIDES
US FAERS
14Cardiac ArrestFAERS: 1US FAERS
15DehydrationFAERS: 1OFFSIDES
US FAERS
16DermatitisFAERS: 1US FAERS
17Full blood count decreasedFAERS: 1OFFSIDES
US FAERS
18HaematotoxicityFAERS: 1US FAERS
19HypersensitivityFAERS: 1US FAERS
20Karnofsky scale worsenedFAERS: 1US FAERS
21Malignant neoplasm progressionFAERS: 1OFFSIDES
US FAERS
22Myocardial InfarctionFAERS: 1US FAERS
23Neutrophil count decreasedFAERS: 1US FAERS
24No adverse eventFAERS: 1US FAERS
25Occupational exposure to productFAERS: 1US FAERS
26Performance status decreasedFAERS: 1US FAERS
27PneumoniaFAERS: 1US FAERS
28Rash erythematousFAERS: 1US FAERS
29Skin toxicityFAERS: 1US FAERS
30Venous thrombosis limbFAERS: 1US FAERS
31White blood cell count decreasedFAERS: 1US FAERS
32Abdominal massOFFSIDES
33Acid refluxOFFSIDES
34Acute myocardial infarctionOFFSIDES
35AdenocarcinomaOFFSIDES
36Adverse eventOFFSIDES
37AmnesiaOFFSIDES
38AnhedoniaOFFSIDES
39AnisocytosisOFFSIDES
40AnorexiaOFFSIDES
41AnxietyOFFSIDES
42AtelectasisOFFSIDES
43Atrial tachycardiaOFFSIDES
44Benign Prostatic HyperplasiaOFFSIDES
45Biliary dilatationOFFSIDES
46Bladder neck obstructionOFFSIDES
47Blood GlucoseOFFSIDES
48Blood pH decreasedOFFSIDES
49Blood potassium increasedOFFSIDES
50Blood urine presentOFFSIDES
51Blurred visionOFFSIDES
52Bone density decreasedOFFSIDES
53Bone lesionOFFSIDES
54Bone painOFFSIDES
55Burning sensationOFFSIDES
56Carbohydrate antigen 27.29 increasedOFFSIDES
57CellulitisOFFSIDES
58Choking sensationOFFSIDES
59ChondromalaciaOFFSIDES
60Chronic Obstructive Airway DiseaseOFFSIDES
61Chronic left ventricular failureOFFSIDES
62Concomitant disease progressionOFFSIDES
63ConfabulationOFFSIDES
64Conjunctival depositOFFSIDES
65Culture positiveOFFSIDES
66DebridementOFFSIDES
67DemyelinationOFFSIDES
68Dental abscessOFFSIDES
69Dental cariesOFFSIDES
70Diastolic dysfunctionOFFSIDES
71Disseminated Intravascular CoagulationOFFSIDES
72DiverticulosisOFFSIDES
73DiverticulumOFFSIDES
74Drug toxicityOFFSIDES
75Duodenal ObstructionOFFSIDES
76DyspepsiaOFFSIDES
77Emotional distressOFFSIDES
78Endodontic procedureOFFSIDES
79EnthesopathyOFFSIDES
80EpistaxisOFFSIDES
81Erectile dysfunctionOFFSIDES
82GastrostomyOFFSIDES
83Gingival HypertrophyOFFSIDES
84Gingival erythemaOFFSIDES
85GranulomaOFFSIDES
86HydronephrosisOFFSIDES
87HypophagiaOFFSIDES
88Incorrect route of drug administrationOFFSIDES
89InfectionOFFSIDES
90Intestinal resectionOFFSIDES
91Jaw lesion excisionOFFSIDES
92Kidney FailureOFFSIDES
93Left Ventricular HypertrophyOFFSIDES
94LethargyOFFSIDES
95Leukopenia neonatalOFFSIDES
96Loose toothOFFSIDES
97Lung consolidationOFFSIDES
98Lymphocyte percentage decreasedOFFSIDES
99MalabsorptionOFFSIDES
100Mental status changesOFFSIDES
101Metabolic acidosisOFFSIDES
102Metastases to thoraxOFFSIDES
103MicrocytosisOFFSIDES
104Monocyte percentage increasedOFFSIDES
105Musculoskeletal PainOFFSIDES
106NauseaOFFSIDES
107Nervous tensionOFFSIDES
108ObstructionOFFSIDES
109Oral polypectomyOFFSIDES
110Oropharyngeal plaqueOFFSIDES
111OsteopeniaOFFSIDES
112OsteoporosisOFFSIDES
113OsteosclerosisOFFSIDES
114Pancreatic CystOFFSIDES
115PeriodontitisOFFSIDES
116Physical disabilityOFFSIDES
117Poor personal hygieneOFFSIDES
118Pulmonary HypertensionOFFSIDES
119Purulent dischargeOFFSIDES
120Respiratory FailureOFFSIDES
121Retroperitoneal lymphadenopathyOFFSIDES
122Rouleaux formationOFFSIDES
123Skin neoplasm excisionOFFSIDES
124Superior Vena Cava SyndromeOFFSIDES
125Synovial CystOFFSIDES
126ThyroiditisOFFSIDES
127Ureteral stent insertionOFFSIDES
128Urethral ObstructionOFFSIDES
129Venous occlusionOFFSIDES
130effusionOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.